-
Bafetinib is an orally active dual Abl/Lyn tyrosine kinase inhibitor. Bafetinib suppresses the growth of Ph+ leukemia cells.
Categories
Others
Archives
- April 2022 (1)
Thanks, your subscription has been confirmed. You will hear from us soon.
Submission failed, please try again later.
Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.